FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907935749> ?p ?o ?g. }

• W2907935749 endingPage "333" @default.
• W2907935749 startingPage "333" @default.
• W2907935749 abstract "<h3>Importance</h3> Neonatal hypoxic-ischemic encephalopathy (HIE) remains a significant cause of neurologic disability. Identifying infants suitable for therapeutic hypothermia (TH) within a narrow therapeutic time is difficult. No single robust biochemical marker is available to clinicians. <h3>Objective</h3> To assess the ability of a panel of candidate microRNA (miRNA) to evaluate the development and severity of encephalopathy following perinatal asphyxia (PA). <h3>Design, Setting, and Participants</h3> This validation study included 2 cohorts. For the discovery cohort, full-term infants with PA were enrolled at birth to the Biomarkers in Hypoxic-Ischemic Encephalopathy (BiHiVE1) study (2009-2011) in Cork, Ireland. Encephalopathy grade was defined using early electroencephalogram and Sarnat score (n = 68). The BiHiVE1 cohort also enrolled healthy control infants (n = 22). For the validation cohort, the BiHiVE2 multicenter study (2013-2015), based in Cork, Ireland (7500 live births per annum), and Karolinska Huddinge, Sweden (4400 live births per annum), recruited infants with PA along with healthy control infants to validate findings from BiHiVE1 using identical recruitment criteria (n = 80). The experimental design was formulated prior to recruitment, and analysis was conducted from June 2016 to March 2017. <h3>Main Outcomes and Measures</h3> Alterations in umbilical cord whole-blood miRNA expression. <h3>Results</h3> From 170 neonates, 160 were included in the final analysis. The BiHiVE1 cohort included 87 infants (21 control infants, 39 infants with PA, and 27 infants with HIE), and BiHiVE2 included 73 infants (control [n = 22], PA [n = 26], and HIE [n = 25]). The BiHiVE1 and BiHiVE2 had a median age of 40 weeks (interquartile range [IQR], 39-41 weeks) and 40 weeks (IQR, 39-41 weeks), respectively, and included 56 boys and 31 girls and 45 boys and 28 girls, respectively. In BiHiVE1, 12 candidate miRNAs were identified, and 7 of these miRNAs were chosen for validation in BiHiVE2. The BiHiVE2 cohort showed consistent alteration of 3 miRNAs; miR-374a-5p was decreased in infants diagnosed as having HIE compared with healthy control infants (median relative quantification, 0.38; IQR, 0.17-0.77 vs 0.95; IQR, 0.68-1.19;<i>P</i> = .009), miR-376c-3p was decreased in infants with PA compared with healthy control infants (median, 0.42; IQR, 0.21-0.61 vs 0.90; IQR, 0.70-1.30;<i>P</i> = .004), and mir-181b-5p was decreased in infants eligible for TH (median, 0.27; IQR, 0.14-1.41) vs 1.18; IQR, 0.70-2.05;<i>P</i> = .02). <h3>Conclusions and Relevance</h3> Altered miRNA expression was detected in umbilical cord blood of neonates with PA and HIE. These miRNA could assist diagnostic markers for early detection of HIE and PA at birth." @default.
• W2907935749 created "2019-01-11" @default.
• W2907935749 creator A5003021083 @default.
• W2907935749 creator A5011863590 @default.
• W2907935749 creator A5019262839 @default.
• W2907935749 creator A5025263935 @default.
• W2907935749 creator A5045423655 @default.
• W2907935749 creator A5079129373 @default.
• W2907935749 creator A5082018025 @default.
• W2907935749 creator A5084014715 @default.
• W2907935749 date "2019-03-01" @default.
• W2907935749 modified "2023-10-16" @default.
• W2907935749 title "Validation of Altered Umbilical Cord Blood MicroRNA Expression in Neonatal Hypoxic-Ischemic Encephalopathy" @default.
• W2907935749 cites W1550814098 @default.
• W2907935749 cites W1747536766 @default.
• W2907935749 cites W1830337612 @default.
• W2907935749 cites W1971588341 @default.
• W2907935749 cites W1977547031 @default.
• W2907935749 cites W1981247323 @default.
• W2907935749 cites W1988137199 @default.
• W2907935749 cites W1992659047 @default.
• W2907935749 cites W1994706770 @default.
• W2907935749 cites W1995150355 @default.
• W2907935749 cites W2004252534 @default.
• W2907935749 cites W2008971670 @default.
• W2907935749 cites W2014086693 @default.
• W2907935749 cites W2016619395 @default.
• W2907935749 cites W2040147525 @default.
• W2907935749 cites W2045050188 @default.
• W2907935749 cites W2068074059 @default.
• W2907935749 cites W2069398669 @default.
• W2907935749 cites W2075396401 @default.
• W2907935749 cites W2076363037 @default.
• W2907935749 cites W2091555142 @default.
• W2907935749 cites W2095876795 @default.
• W2907935749 cites W2097233439 @default.
• W2907935749 cites W2106242254 @default.
• W2907935749 cites W2107277218 @default.
• W2907935749 cites W2111848990 @default.
• W2907935749 cites W2112187582 @default.
• W2907935749 cites W2132093971 @default.
• W2907935749 cites W2134658679 @default.
• W2907935749 cites W2135836598 @default.
• W2907935749 cites W2155028837 @default.
• W2907935749 cites W2169332120 @default.
• W2907935749 cites W2169597792 @default.
• W2907935749 cites W2179438025 @default.
• W2907935749 cites W2192080449 @default.
• W2907935749 cites W2266501231 @default.
• W2907935749 cites W2272525849 @default.
• W2907935749 cites W2313599265 @default.
• W2907935749 cites W2377937708 @default.
• W2907935749 cites W2405166856 @default.
• W2907935749 cites W2508010945 @default.
• W2907935749 cites W2532370181 @default.
• W2907935749 cites W2776114597 @default.
• W2907935749 cites W2891039026 @default.
• W2907935749 cites W4233815773 @default.
• W2907935749 cites W4247045785 @default.
• W2907935749 cites W4248133266 @default.
• W2907935749 cites W4254637496 @default.
• W2907935749 doi "https://doi.org/10.1001/jamaneurol.2018.4182" @default.
• W2907935749 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6439719" @default.
• W2907935749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30592487" @default.
• W2907935749 hasPublicationYear "2019" @default.
• W2907935749 type Work @default.
• W2907935749 sameAs 2907935749 @default.
• W2907935749 citedByCount "30" @default.
• W2907935749 countsByYear W29079357492019 @default.
• W2907935749 countsByYear W29079357492020 @default.
• W2907935749 countsByYear W29079357492021 @default.
• W2907935749 countsByYear W29079357492022 @default.
• W2907935749 countsByYear W29079357492023 @default.
• W2907935749 crossrefType "journal-article" @default.
• W2907935749 hasAuthorship W2907935749A5003021083 @default.
• W2907935749 hasAuthorship W2907935749A5011863590 @default.
• W2907935749 hasAuthorship W2907935749A5019262839 @default.
• W2907935749 hasAuthorship W2907935749A5025263935 @default.
• W2907935749 hasAuthorship W2907935749A5045423655 @default.
• W2907935749 hasAuthorship W2907935749A5079129373 @default.
• W2907935749 hasAuthorship W2907935749A5082018025 @default.
• W2907935749 hasAuthorship W2907935749A5084014715 @default.
• W2907935749 hasBestOaLocation W29079357491 @default.
• W2907935749 hasConcept C126322002 @default.
• W2907935749 hasConcept C187212893 @default.
• W2907935749 hasConcept C201903717 @default.
• W2907935749 hasConcept C203014093 @default.
• W2907935749 hasConcept C2776955114 @default.
• W2907935749 hasConcept C2778080812 @default.
• W2907935749 hasConcept C2778621155 @default.
• W2907935749 hasConcept C2779914510 @default.
• W2907935749 hasConcept C2780164069 @default.
• W2907935749 hasConcept C2909832856 @default.
• W2907935749 hasConcept C71924100 @default.
• W2907935749 hasConcept C72563966 @default.
• W2907935749 hasConceptScore W2907935749C126322002 @default.
• W2907935749 hasConceptScore W2907935749C187212893 @default.
• W2907935749 hasConceptScore W2907935749C201903717 @default.

• next